Suppression of proinflammatory cytokine production in macrophages by lansoprazole

Pediatric Surgery International

Volumn 22, Issue 11, 2006, Pages 915-923

  Hinoki, Akinari ^a   Yoshimura, Kazunori ^a   Fujita, Keiko ^a   Akita, Masumi ^a   Ikeda, Rie ^a   Nagashima, Masabumi ^a   Nomura, Masahiko ^a   Satomi, Akira ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ATPase; Bafilomycin A1; Cytokine; Lansoprazole; Macrophage

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE INHIBITOR; BAFILOMYCIN A1; CYTOKINE; DIMETHYL SULFOXIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LANSOPRAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG MECHANISM; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADENOSINE TRIPHOSPHATASES; ANIMALS; CYTOKINES; MACROPHAGES; MICE; RNA, MESSENGER;

EID: 33750362795     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-006-1767-8     Document Type: Article

References (29)

1. Mahida YR (2000) The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 6:21-33
2. Sawa Y, Oshitani N, Adachi K et al (2003) Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int J Mol Med 11:175-179
3. Ogata H, Hibi T (2003) Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des 9:1107-1113
4. Hibi T, Inoue N, Ogata H et al (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J Gastroenterol 38:36-42
5. Baert F, Noman M, Vermeire S et al (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348:601-608
6. Ito H (2005) Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol 40:32-34
7. Ito H, Takazoe M, Fukuda Y et al (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126:989-996
8. Yoshida N, Yoshikawa T, Tanaka Y et al (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 14:74-81
9. Ohara T, Arakawa T (1999) Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci 44:1710-1715
10. Bicakci U, Tander B, Ariturk E et al (2005) Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 21:800-805
11. Suzuki M, Mori M, Miura S et al (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21:727-731
12. Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617-621
13. Suzuki M, Nakamura M, Mori M et al (1995) Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol 20:93-96
14. Dickinson JB (1994) Is omeprazole helpful in inflammatory bowel disease? J Clin Gastroenterol 18:317-319
15. Valori RM, Cockel R (1990) Omeprazole for duodenal ulceration in Crohn's disease. BMJ 300:438-439
16. Forgac M (1989) Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 69:765-796
17. Nelson N (1989) Structure, molecular genetics, and evolution of vacuolar H+-ATPases. J Bioenerg Biomembr 21:553-571
18. Moriyama Y, Futai M (1990) H(+)-ATPase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles. Biochem Biophys Res Commun 173:443-448
19. Vaananen HK, Karhukorpi EK, Sundquist K et al (1990) Evidence for the presence of a proton pump of the vacuolar (H+)-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 111:1305-1311
20. Martinez-Zaguilan R, Lynch RM, Martinez GM et al (1993) Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 265:1015-1029
21. Yoshimura K, Kametani F, Shimoda Y et al (2001) Antigens of monoclonal antibody NB3C4 are novel markers for oligodendrocytes. Neuroreport 12:417-421
22. Bunge RP, Wood P (1973) Studies on the transplantation of spinal cord tissue in the rat. I. The development of a culture system for hemisections of embryonic spinal cord. Brain Res 57:261-276
23. Carmosino M, Mazzone A, Laforenza U et al (2005) Altered expression of aquaporin 4 and H(+)/K(+)-ATPase in the stomachs of peptide YY(PYY)transgenic mice. Biol Cell 97:735-742
24. Yamamoto M, Yoshizaki K, Kishimoto T et al (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164:4878-4882
25. Ito H, Hirotani T, Yamamoto M et al (2002) Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease. J Gastroenterol 37:56-61
26. Nakamura M, Asada M, Atsuda K et al (2005) Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. Inflammopharmacology 13:303-315
27. Kuroda M, Yoshida N, Ichikawa H et al (2006) Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 17:89-93
28. Ohta T, Numata M, Yagishita H et al (1996) Expression of 16 kDa proteolipid of vacuolar-type H(+)- ATPase in human pancreatic cancer. Br J Cancer 73:1511-1517
29. Bidani A, Reisner BS, Haque AK et al (2000) Bactericidal activity of alveolar macrophages is suppressed by V-ATPase inhibition. Lung 178:91-104